Log in

NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

+0.10 (+0.56 %)
(As of 08/5/2020 04:00 PM ET)
Today's Range
Now: $18.08
50-Day Range
MA: $17.42
52-Week Range
Now: $18.08
Volume879,021 shs
Average Volume999,028 shs
Market Capitalization$1.73 billion
P/E Ratio34.77
Dividend Yield5.56%
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.
Read More
Caretrust REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.5Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.96 out of 5 stars

Industry, Sector and Symbol

Industry Real estate investment trusts
Current SymbolNASDAQ:CTRE
Previous SymbolNASDAQ:CTREV



Sales & Book Value

Annual Sales$163.40 million
Cash Flow$1.09 per share
Book Value$9.71 per share


Net Income$46.36 million


Market Cap$1.73 billion
Next Earnings Date8/6/2020 (Confirmed)
+0.10 (+0.56 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTRE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTRE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Caretrust REIT (NASDAQ:CTRE) Frequently Asked Questions

How has Caretrust REIT's stock been impacted by COVID-19 (Coronavirus)?

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CTRE stock has increased by 6.4% and is now trading at $18.08.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of Caretrust REIT?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Caretrust REIT

When is Caretrust REIT's next earnings date?

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020.
View our earnings forecast for Caretrust REIT

How were Caretrust REIT's earnings last quarter?

Caretrust REIT Inc (NASDAQ:CTRE) announced its quarterly earnings results on Thursday, May, 7th. The real estate investment trust reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.34 by $0.14. The real estate investment trust had revenue of $44.34 million for the quarter, compared to analyst estimates of $43.20 million. Caretrust REIT had a net margin of 29.53% and a return on equity of 5.32%.
View Caretrust REIT's earnings history

How often does Caretrust REIT pay dividends? What is the dividend yield for Caretrust REIT?

Caretrust REIT declared a quarterly dividend on Wednesday, June 17th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.25 per share on Wednesday, July 15th. This represents a $1.00 annualized dividend and a dividend yield of 5.53%. The ex-dividend date is Monday, June 29th.
View Caretrust REIT's dividend history

What price target have analysts set for CTRE?

7 Wall Street analysts have issued 12-month price targets for Caretrust REIT's stock. Their forecasts range from $13.00 to $26.00. On average, they expect Caretrust REIT's stock price to reach $21.71 in the next twelve months. This suggests a possible upside of 20.1% from the stock's current price.
View analysts' price targets for Caretrust REIT

Has Caretrust REIT been receiving favorable news coverage?

News articles about CTRE stock have trended somewhat negative recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Caretrust REIT earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Caretrust REIT

Are investors shorting Caretrust REIT?

Caretrust REIT saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 1,340,000 shares, a decrease of 18.8% from the July 15th total of 1,650,000 shares. Based on an average daily volume of 922,100 shares, the days-to-cover ratio is presently 1.5 days. Currently, 1.4% of the company's stock are short sold.
View Caretrust REIT's Current Options Chain

Who are some of Caretrust REIT's key competitors?

What other stocks do shareholders of Caretrust REIT own?

Who are Caretrust REIT's key executives?

Caretrust REIT's management team includes the following people:
  • Mr. Gregory K. Stapley J.D., Chairman, Pres & CEO (Age 59)
  • Mr. William M. Wagner, CFO, Treasurer & Sec. (Age 53)
  • Mr. David M. Sedgwick, Chief Operating Officer (Age 43)
  • Mr. Mark D. Lamb, Chief Investment Officer
  • Ms. Lauren Beale, Controller

What is Caretrust REIT's stock symbol?

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

Who are Caretrust REIT's major shareholders?

Caretrust REIT's stock is owned by a number of institutional and retail investors. Top institutional shareholders include PGGM Investments (7.80%), Principal Financial Group Inc. (0.83%), Foundry Partners LLC (0.49%), Swiss National Bank (0.22%), Sumitomo Mitsui Trust Holdings Inc. (0.22%) and Scout Investments Inc. (0.22%).
View institutional ownership trends for Caretrust REIT

Which major investors are selling Caretrust REIT stock?

CTRE stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Principal Financial Group Inc., Jaguar Listed Property LLC, WINTON GROUP Ltd, Virtus ETF Advisers LLC, NN Investment Partners Holdings N.V., Texas Permanent School Fund, and Hancock Whitney Corp.
View insider buying and selling activity for Caretrust REIT

Which major investors are buying Caretrust REIT stock?

CTRE stock was acquired by a variety of institutional investors in the last quarter, including Foundry Partners LLC, New York State Teachers Retirement System, Mackay Shields LLC, Leap Investments LP, Dupont Capital Management Corp, Swiss National Bank, SG Americas Securities LLC, and Telemus Capital LLC.
View insider buying and selling activity for Caretrust REIT

How do I buy shares of Caretrust REIT?

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Caretrust REIT's stock price today?

One share of CTRE stock can currently be purchased for approximately $18.08.

How big of a company is Caretrust REIT?

Caretrust REIT has a market capitalization of $1.73 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

What is Caretrust REIT's official website?

The official website for Caretrust REIT is www.caretrustreit.com.

How can I contact Caretrust REIT?

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.